NCT02119715: A Phase II Study Comparing Pegylated rhG-CSF(HHPG-19K) and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy |
|
|
| Completed | 2 | 182 | RoW | Pegylated rhG-CSF 100μg/kg, HHPG-19K 100µg/kg, Pegylated rhG-CSF:150 μg/kg, HHPG-19K 150μg/kg, rhG-CSF 5 μg/kg/day, Jie Xin 5 μg/kg/day | Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer, Neutropenia, Febrile Neutropenia | 08/12 | 12/12 | | |